Press Releases

2023

Walgreens and Freenome Establish Partnership to Increase Diversity in Research for the Early Detection of Cancer

June 15, 2023

Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd

May 22, 2023

Freenome Adds University Of Chicago As A Partner For Its Vallania Study

April 12, 2023

Freenome Adds Renown Health As Partner For The Sanderson Study

March 28, 2023

Freenome Presents A Subject Population Analysis Of A Clinical Study Using A Multiomics Blood Test For The Early Detection Of Colorectal Cancer

March 6, 2023

Freenome Partners with Geisinger for the Sanderson Study

January 18, 2023

2022

Freenome Presents Research Highlighting The Promise of Identifying Drug-Response Biomarker for DLBCL Patients

December 12, 2022

Freenome Adds Several Community Partners to Clinical Study for the Early Detection of Cancer

November 1, 2022

Freenome Launches Study of Multiple Cancers Pairing Multiomics with Real-World Data

September 6, 2022

Freenome Continues Growth, Adds Three New Leaders

June 2, 2022

Freenome Research Underscores Clinical Utility of Screening Tests That Detect Adenomas

May 25, 2022

Freenome and Morehouse Present Research on Study Participation Among Black Patients

May 23, 2022

Largest Clinical Study Validating a Blood-based Colorectal Screening Test Completes Enrollment

May 10, 2022

Freenome and Merck KGaA, Darmstadt, Germany to Present Data on Combination of Multiomics Profiling and Computational Modeling at AACR Meeting

April 13, 2022

Freenome Presents Research That Highlights the Significance of Detecting Adenomas in Any Test That Screens for Colorectal Cancer

April 11, 2022

Lance Baldo Joins Freenome as Chief Medical Officer

April 4, 2022

Research Highlights Changing Factors that Influence Colorectal Cancer Screening Adherence

March 15, 2022

Freenome Launches the Vallania Study for the Early Detection of Multiple Cancers

February 28, 2022

Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRC

January 24, 2022

Significant Investment Accelerates Freenome’s Multiomics Platform for the Early Detection of Cancer

January 11, 2022

2021

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

December 7, 2021

Freenome Partners with Siemens Healthineers for Breast Cancer Research

December 1, 2021

Morehouse School of Medicine and Freenome Present Research Demonstrating High Enrollment Rates for African Americans in Clinical Trial

October 27, 2021

Freenome Shows Continued Leadership in Colorectal Cancer Research

October 25, 2021

Research Shows the Clinical Benefits of Detecting Adenomas

June 7, 2021

Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers

April 10, 2021

2020

PREEMPT CRC Trial for Blood-Based Test to Detect Colon Cancer Has Expanded to Enroll Patients From Anywhere in the Continental U.S. During COVID-19 Pandemic

August 26, 2020

Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

August 26, 2020

Freenome Announces Initiation of the PREEMPT CRC Clinical Trial, a Registrational Study for the Early Detection and Prevention of Colorectal Cancer Using a Multiomics Blood Test

May 26, 2020

Freenome Announces Encouraging Performance Data for Its Multiomics Blood Test to Detect Early-Stage Colorectal Cancer in a Prospective, Multi-Center Clinical Study

January 23, 2020

2019

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

August 26, 2019

Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection

July 24, 2019

Freenome Bolsters Scientific Leadership, Naming Genomic-Medicine Pioneer, Jimmy Lin, As New Chief Scientific Officer

April 30, 2019

2018

Freenome Unveils Promising Early Data on Colorectal Cancer Screening Test at American College of Gastroenterology Annual Meeting

October 9, 2018

Freenome’s IMPACT Advisory Board Brings Strategic Insight and Real-World Experience to AI-Genomics Cancer Tests

July 12, 2018

Christian Doppler Research Grant Awarded to Freenome and the Medical University of Graz to Advance Understanding of Gene Expression Changes in Cancer Using Circulating Biomarkers

May 31, 2018

Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment

April 24, 2018

Institut Curie and Freenome Announce a Strategic Collaboration in Cell-Free DNA Analysis Using Machine Learning Technology

March 29, 2018

2017

Invitae Chairman Randy Scott Joins Freenome Board of Directors

December 21, 2017

Freenome Announces Formation of Scientific Advisory Board

October 18, 2017

Freenome Announces Series A Extension Led by Section 32

August 28, 2017

Freenome Appoints Abraham Tzou, M.D. Vice President, Regulatory Affairs

August 2, 2017